lobbying_filings_raw: b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 102607 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | 2018-10-22T11:50:44.917000-04:00 | 500000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f/", "filing_uuid": "b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2018, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "500000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Shawn Friesen", "dt_posted": "2018-10-22T11:50:44.917000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1445 New York Avenue, NW, #800", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 1331, "url": "https://lda.senate.gov/api/v1/registrants/1331/", "house_registrant_id": 30329, "name": "AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION", "description": null, "address_1": "1201 Pennsylvania Ave N.W.", "address_2": "Suite 540", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "KARRY LAVIOLETTE", "contact_telephone": "+1 202-230-1350", "dt_updated": "2026-01-12T11:21:07.020779-05:00"}, "client": {"id": 102607, "url": "https://lda.senate.gov/api/v1/clients/102607/", "client_id": 12, "name": "AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-14"}, "lobbying_activities": [{"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Advocate against H.R. 1150, the Tanning Tax Repeal Act of 2017, and S. 2600, the Tanning Tax Repeal act of 2018, to repeal excise tax on indoor tanning services.\nAdvocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S.85/H.R. 394, Restoring Access to Medication Act and H.R. 6199, the Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018.\nAdvocate against the inclusion of the repeal of the excise tax on indoor tanning services in the Save American Workers Act (H.R. 3798).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription.\nLobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting.\nLobby members of Congress regarding issues related to telemedicine.\nAdvocate for increased transparency regarding drug pricing.\nLobby members of the House to join the Congressional Skin Cancer Caucus.\nLobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps.\nAdvocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks.\nSupport H.R. 2871, Preserving Patient Access to Compounded Medications Act.\nSupport H.R. 2077, Restoring Patients Voice Act.\nSupport H.R. 1316, Prescription Drug Price Transparency Act.\nSupport H.R. 2051, Fair Access for Safe and Timely Generics Act.\nSupport H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act.\nSupport H.R. 2999, Patients Access to Treatments Act.\nSupport H.R. 3928, the Truth in Healthcare Marketing Act of 2017.\nSupport S. 637, C-THRU Act.\nSupport S. 989, Ensuring Childrens Access to Specialty Care Act.\nSupport S. 2553, Know the Lowest Prices Act.\nSupport S. 2554, Patient Right to Know Drug Prices Act.\nSupport H.R. 5958, Phair Pricing Act.\nSupport H.R. 5343, Prescription Transparency Act.\nSupport H.R. 6689/S. 3368, Ensuring Lasting Smiles Act.\nAdvocate for relief for from prior authorization requirements under Medicare Advantage and Medicare Part D plans.\nSupport H.R. 4841/H.R. 5773/Section 6062 of H.R. 6 (SUPPORT for Patients & Communities Act), Standardizing Electronic Prior Authorization for Safe Prescribing Act and S. 2908, Electronic Prior Authorization in Medicare Part D Act.\nSupport sunscreen related provisions in S. 2315, OTC Drug Safety, Innovation & Reform Act/H.R. 5333, OTC Monograph Safety, Innovation, & Reform Act.\nSupport pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. \nAdvocate for access to dermatological procedures for veterans through the Veterans Choice Program.\nAdvocate for the continued funding of Community Health Centers.\nAdvocate against including physician advocacy and membership organization in the Physician Payment Sunshine Act requirements as originally included in S. 3000; advocated against inclusion in S. Amendment 4013 to H.R. 6.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "DEF", "general_issue_code_display": "Defense", "description": "Support funding for Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD) in the Fiscal Year 2019 (FY19) Defense Appropriations bill (H.R. 6157, S. 3159).\nSupport dedicated Melanoma research funding, outside of the Peer-Reviewed Cancer Research Program, at the DoD (H.R. 6157).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "VET", "general_issue_code_display": "Veterans", "description": "Advocate for access to dermatological procedures for veterans through the Veterans Choice Program, included in the VA MISSION Act (Public Law No: 115-182).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage.\nAdvocate for Congressional support for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS).\nAdvocate for increased funding and reforms to Graduate Medical Education. \nAdvocate for a new study on physician shortage to be conducted by the Health Resources and Services Administration. \nLobby members of Congress regarding improvements to Health Information Technology implementation.\nSupport provisions to allow Medicare Advantage plans to include telehealth as a benefit.\nAdvocate for improving disease management and care coordination for patients with chronic diseases.\nSupport preservation of the In-Offices Ancillary Services Exemption (IOASE) under Stark Law regarding physician self-referral and oppose repeal of the in-office ancillary and physician services exception. \nAdvocate regarding possible changes to IOASE and Stark Law relative to implementation of Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110)\nSupport H.R. 4206/S.2051 Medicare Care Coordination Improvement Act of 2017 \nAdvocate for Congressional support for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS).\nOppose elimination of a Merit-Based Incentive Payment System. \nAdvocate allowing further appeals process within the Quality Payment Program. \nAdvocate against H.R. 2066, Promoting Integrity in Medicare Act of 2017.\nAdvocate for relief for from prior authorization requirements under Medicare Advantage and Medicare Part D plans.\nSupport H.R. 4841/H.R. 5773/Section 6062 of H.R. 6 (SUPPORT for Patients & Communities Act), Standardizing Electronic Prior Authorization for Safe Prescribing Act and S. 2908, Electronic Prior Authorization in Medicare Part D Act\nAdvocate expanding the period for reporting and returning overpayments beyond the 60 days statutorily required under audits by Recovery Audit Contractors (RACs). \nSupport S. 2553, Know the Lowest Price Act.\nLobby Congress to urge CMS to withdraw evaluation and management (E/M) coding and payment proposals, including the Modifier 25 proposal or what is also sometimes referred to as the multiple procedure payment reduction (MPPR), from 2019 Medicare Physician Fee Schedule.\nLobby Congress to urge CMS to strengthen Qualified Clinical Data Registries (QCDRs) by removing barriers that restrict access to data from EHRs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, and Food and Drug Administration in FY19 Labor/HHS/Education Appropriations (H.R. 6470/S. 3158; H.R. 6157).\nAdvocate for The National Hansens Disease Program funding in FY19 Labor/HHS/Education Appropriations (H.R. 6470, S. 3158; H.R. 6157).\nSupport funding for Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD) in the Fiscal Year 2019 (FY19) Defense Appropriations bill (H.R. 6157, S. 3159).\nSupport dedicated Melanoma research funding, outside of the Peer-Reviewed Cancer Research Program, at the DoD (H.R. 6157).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "IMM", "general_issue_code_display": "Immigration", "description": "Support legislation, such as, S. 1615/ H.R. 3440 DREAM Act, which would enable those individuals eligible with Deferred Action for Childhood Arrivals status are able to continue their employment, education, training, and research.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription.\nLobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting.\nSupport H.R. 2871, Preserving Patient Access to Compounded Medications Act.\nSupport H.R. 1316, Prescription Drug Price Transparency Act\nSupport S. 637, C-THRU Act.\nSupport S. 2553, Know the Lowest Price Act.\nSupport S. 2554, Patient Right to Know Drug Prices Act.\nSupport H.R. 5958, Phair Pricing Act.\nSupport H.R. 5343, Prescription Transparency Act.\nSupport sunscreen related provisions in S. 2315, OTC Drug Safety, Innovation & Reform Act/H.R. 5333, OTC Monograph Safety, Innovation, & Reform Act.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, and Food and Drug Administration in FY19 Labor/HHS/Education Appropriations (H.R. 6470/S. 3158; H.R. 6157).\nAdvocate for The National Hansens Disease Program funding in FY19 Labor/HHS/Education Appropriations (H.R. 6470, S. 3158; H.R. 6157).\nSupport funding for Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD) in the Fiscal Year 2019 (FY19) Defense Appropriations bill (H.R. 6157, S. 3159).\nSupport dedicated Melanoma research funding, outside of the Peer-Reviewed Cancer Research Program, at the DoD (H.R. 6157).\nLobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting (H.R. 3268).\nSupport maintaining the Prevention and Public Health Fund (PPHF).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TOR", "general_issue_code_display": "Torts", "description": "Advocate for legislation to enact medical liability reforms.\nSupport H.R. 1704, Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act.\nSupport H.R. 1215, Protecting Access to Care Act.\nSupport H.R. 1876, Good Samaritans Health Professionals Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56785, "prefix": null, "prefix_display": null, "first_name": "SHAWN", "nickname": null, "middle_name": null, "last_name": "FRIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 57630, "prefix": null, "prefix_display": null, "first_name": "CHRISTINE", "nickname": null, "middle_name": null, "last_name": "O'CONNOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63400, "prefix": null, "prefix_display": null, "first_name": "BLAKE", "nickname": null, "middle_name": null, "last_name": "MCDONALD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63901, "prefix": null, "prefix_display": null, "first_name": "MICHELLE", "nickname": null, "middle_name": null, "last_name": "MATHY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |